Open AccessInvestigation of Chromosome 1 Aberrations in the Lymphocytes of Prostate Cancer and Benign Prostatic Hyperplasia Patients by Fluorescence in situ Hybridization
Author(s) -
Justyna Miszczyk,
Mikołaj Przydacz,
M. Zembrzuski,
Piotr Chłosta
Publication year - 2021
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s293249
Subject(s) - prostate cancer , fluorescence in situ hybridization , hyperplasia , radiation therapy , cancer , prostate , medicine , radiosensitivity , oncology , chromosome , pathology , biology , cancer research , genetics , gene
Radiotherapy is one of the most common treatments for prostate cancer. Finding a useful predictor of the therapeutic outcome is crucial as it increases the efficacy of treatment planning. This study investigated the individual susceptibility to radiation based on chromosome 1 aberration frequency measured by the FISH (fluorescence in situ hybridization) method.